Atlas Trials

A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants

Clinical trial NCT07146750 · COMPLETED

Trial details

NCT number
NCT07146750
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2025-08-25
Primary completion
2026-04-08
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.